Skip to main content

Theravance Biopharma, Inc.

TBPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001583107

In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Theravance Biopharma, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
132
+6 vs. Q4 2024
Shares held
44.9M
+503.4K (+1.1%) vs. Q4 2024
Total value
$400.9M
−$16.8M (−4.0%) vs. Q4 2024
New holders
23
36 more added
Sold out
17
48 more reduced

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TBPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 132 institutions
Q1 2021: 107 institutionsQ2 2021: 109 institutionsQ3 2021: 119 institutionsQ4 2021: 116 institutionsQ1 2022: 121 institutionsQ2 2022: 113 institutionsQ3 2022: 123 institutionsQ4 2022: 119 institutionsQ1 2023: 114 institutionsQ2 2023: 119 institutionsQ3 2023: 115 institutionsQ4 2023: 118 institutionsQ1 2024: 121 institutionsQ2 2024: 132 institutionsQ3 2024: 119 institutionsQ4 2024: 128 institutionsQ1 2025: 132 institutionsQ2 2025: 135 institutionsQ3 2025: 161 institutionsQ4 2025: 169 institutionsQ1 2026: 173 institutionsQ2 2026: 179 institutions
Value heldQ1 2025: $400.9M
Q1 2021: $1.09BQ2 2021: $883.1MQ3 2021: $448.8MQ4 2021: $655.6MQ1 2022: $602.5MQ2 2022: $582.0MQ3 2022: $649.8MQ4 2022: $696.1MQ1 2023: $652.6MQ2 2023: $546.3MQ3 2023: $438.5MQ4 2023: $548.7MQ1 2024: $430.6MQ2 2024: $399.5MQ3 2024: $368.9MQ4 2024: $422.4MQ1 2025: $400.9MQ2 2025: $512.2MQ3 2025: $706.3MQ4 2025: $927.2MQ1 2026: $814.2MQ2 2026: $817.5M
Institutions holding TBPH and their total value by quarter
QuarterHoldersValue
Q2 2026179$817.5M
Q1 2026173$814.2M
Q4 2025169$927.2M
Q3 2025161$706.3M
Q2 2025135$512.2M
Q1 2025132$400.9M
Q4 2024128$422.4M
Q3 2024119$368.9M
Q2 2024132$399.5M
Q1 2024121$430.6M
Q4 2023118$548.7M
Q3 2023115$438.5M
Q2 2023119$546.3M
Q1 2023114$652.6M
Q4 2022119$696.1M
Q3 2022123$649.8M
Q2 2022113$582.0M
Q1 2022121$602.5M
Q4 2021116$655.6M
Q3 2021119$448.8M
Q2 2021109$883.1M
Q1 2021107$1.09B

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Theravance Biopharma, Inc.; share changes are against Q4 2024.

Institutions holding TBPH in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
JPMorgan Chase & Co156,817$1.40M0.00%−62,751−28.6%Reduced
Jacobs Levy Equity Management, Inc161,797$1.44M0.01%−276,666−63.1%Reduced
Trexquant Investment LP165,424$1.48M0.02%+14,341+9.5%Added
Acadian Asset Management LLC174,594$1.55M0.00%+174,451+121,993.7%Added
Gsa Capital Partners LLP182,350$1.63M0.15%+19,363+11.9%Added
Tudor Investment Corp Et Al196,573$1.76M0.02%−50.0%Reduced
Macquarie Group Ltd208,783$1.86M0.00%00.0%Unchanged
Goldman Sachs Group Inc210,536$1.88M0.00%−14,567−6.5%Reduced
Arrowstreet Capital, Limited Partnership221,469$1.98M0.00%+221,469New
Tang Capital Management LLC262,896$2.35M0.13%00.0%Unchanged
Charles Schwab Investment Management Inc287,716$2.57M0.00%−6,220−2.1%Reduced
Millennium Management LLC291,534$2.60M0.00%+98,695+51.2%Added
BNP Paribas Arbitrage, SA296,172$2.64M0.00%−9,443−3.1%Reduced
Northern Trust Corp349,417$3.12M0.00%−40,563−10.4%Reduced
Nuveen, LLC374,952$3.35M0.00%+374,952New
Morgan Stanley384,987$3.44M0.00%−7,346−1.9%Reduced
UBS Group AG417,621$3.73M0.00%+243,376+139.7%Added
Citadel Advisors LLC438,709$3.92M0.00%+124,087+39.4%Added
Bank of America Corp463,228$4.14M0.00%−18,247−3.8%Reduced
Dimensional Fund Advisors LP643,838$5.75M0.00%+90,125+16.3%Added
Geode Capital Management, LLC890,567$7.95M0.00%+27,765+3.2%Added
D. E. Shaw & Co., Inc.920,302$8.22M0.01%+86,359+10.4%Added
Camber Capital Management LP1,000,000$8.93M0.56%00.0%Unchanged
State Street Corp1,066,775$9.53M0.00%−155,695−12.7%Reduced
Oasis Management Co Ltd.1,118,935$9.99M3.36%+3,170+0.3%Added
Park West Asset Management LLC1,804,244$16.1M1.32%+11,256+0.6%Added
Vanguard Group Inc2,080,463$18.6M0.00%+69,919+3.5%Added
Irenic Capital Management LP2,760,948$24.7M3.74%00.0%Unchanged
BlackRock, Inc.3,451,329$30.8M0.00%−260,974−7.0%Reduced
Newtyn Management, LLC4,757,403$42.5M6.72%00.0%Unchanged
Weiss Asset Management LP7,457,060$66.6M1.78%00.0%Unchanged
Madison Avenue Partners, LP9,511,150$84.9M7.21%00.0%Unchanged
UBS Asset Management Americas Inc0$00.00%−150,039−100.0%Sold out
Swiss National Bank0$00.00%−71,742−100.0%Sold out
Ensign Peak Advisors, Inc0$00.00%−60,907−100.0%Sold out
State of Wisconsin Investment Board0$00.00%−58,001−100.0%Sold out
Virtus ETF Advisers LLC0$00.00%−35,426−100.0%Sold out
Janus Henderson Group PLC0$00.00%−24,666−100.0%Sold out
Engineers Gate Manager LP0$00.00%−19,832−100.0%Sold out
ClearAlpha Technologies LP0$00.00%−11,586−100.0%Sold out
Teacher Retirement System of Texas0$00.00%−10,937−100.0%Sold out
Arizona State Retirement System0$00.00%−10,649−100.0%Sold out
Man Group plc0$00.00%−10,328−100.0%Sold out
Gerber, LLC0$00.00%−10,000−100.0%Sold out
KLP Kapitalforvaltning AS0$00.00%−7,300−100.0%Sold out
Creative Planning0$00.00%−603−100.0%Sold out
Venturi Wealth Management, LLC0$00.00%−526−100.0%Sold out
Parallel Advisors, LLC0$00.00%−240−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−14−100.0%Sold out
Nuveen Asset Management, LLC––––Not filed
Global Retirement Partners, LLC––––Not filed